Compare Cell Therapeutics vs Quantum Immunologics
Customers evaluate the quality of Cell Therapeutics's products using the following success metrics.
Overview
Cell Therapeutics is 33 yrs old and is based in United States.
CTI is committed to developing, acquiring, and commercializing innovative treatments for cancer. In the company's pursuit of making cancer more treatable, they are developing a diversified portfolio of oncology products focused on identifying and developing new, less toxic, and more effective ways to treat cancer.
Quantum Immunologics is based in United States
Quantum Immunologics, Inc. ("QI") is a research-driven biotechnology company that is working on discoveries in immunotherapy science. QI is dedicated to the research, development and production of technologies that focus on the treatments and diagnoses of cancer and other diseases related to the immune system. Leveraging an expansive pipeline of biopharmaceutical innovations, QI remains committed to advancing medicine with the ultimate goal of dramatically improving lives.
Demo Video
Leadership
Craig W. Philips (President)
Charles Broes (Chief Executive Officer)
Funding
Investors
EW Healthcare Partners, ProQuest Investments
Mentor Capital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Cell Therapeutics has not claimed their profile.
Work for Cell Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cell Therapeutics?
Claim your profile now.
Information not available because Quantum Immunologics has not claimed their profile.
Work for Quantum Immunologics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Quantum Immunologics?
Claim your profile now.